The Nuffield Centre for International Health and Development at the University of Leeds is a University department doing health services research and masters of public health and management courses. The communicable disease (COMDIS) health service delivery (HSD) consortium is a DFID UK funded operational research and service development programme. There are eight partner country/organisations in Africa, south Asia/ China. COMDIS HSD partner organisations have developed TB, HIV-ART, malaria and other service guidelines and materials for quality care and implementation. Also evaluating these and specific interventions for quality, patient-centred care and adherence to treatment.contributes to the development of new knowledge in systems to improve health in low and middle income countries. We have a strong reputation in the fields of health services delivery and health policy, planning and management. The Nuffield's work combines developing theoretical knowledge and application of such knowledge. There are three strands to our work:• Research, focusing on generating theory and evidence to inform strategy, policy and practice. • Teaching and learning programmes, aimed at the development, management and leadership of systems which promote health and wider well-being. • Consultancy work, which enables us to help individuals and organizations make a difference by transferring and applying knowledge to real world health problems.

Total number of staff in your organization:

11 - 25

Number of full-time staff who are directly involved with TB:

6 - 10

Number of part-time staff who are directly involved with TB:

1 - 5

Number of volunteers who are directly involved with TB:

1 - 5

What is your organization's annual budget (USD) dedicated to TB?

$100,001-$500,000

How did you hear about the Stop TB Partnership:

Involvement in TB control provision

If you were informed or referred by another partner of the Stop TB Partnership please tell us who:

Why do you wish join the Stop TB Partnership:

Network with other partners

Are you a member of a Stop TB national partnership:

United Kingdom

Are you in contact with your national TB programme:

No

Please tell us how your organization is contributing to your country's national TB control plan:

Through COMDIS HSD consortium led from Leeds supports national TB programmes in Africa and south Asia and China. With partners we develop services and evaluate them, prior to scale up. We have generic packages for regular and drug resistant TB. In Pakistan, Nepal and China we are doing MDR TB operational research.

Geographical Reach

Which country is your headquarters located in:

United Kingdom of Great Britain and Northern Ireland

Which WHO region is the main focus of your work:

South East Asian

Which countries do you do operate in:(This includes countries you are conducting activities in)

BangladeshChinaGhanaNepalPakistanSwazilandUganda

Specializations

Research and Development

Specializations in Countries

Unknown

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:Through the COMDIS HSD research and development programme and its partners we are developing and evaluating strategies and materials to ensure effective scale-up of TB.

Drug-Resistant TB:Through the COMDIS HSD research and development programme and its partners we are developing and evaluating strategies and materials to ensure effective scale-up of MDR TB in China, Nepal and Pakistan - including a randomised controlled trial of hospital vs fully community-based care.

TB-HIV:Through the COMDIS HSD research and development programme and partners in Africa we are developing and evaluating strategies and materials to deliver integrated and decentralised to health centre and community TB-HIV care.

Research:Through the COMDIS HSD research and development programme and its partners we are developing and evaluating strategies and materials to ensure effective scale-up of TB. These include interviews and focus groups to understand the situation, and evaluation through controlled trials alongside intervention of innovative delivery strategies.